Crossmark

Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition

Crossref DOI link: https://doi.org/10.1016/j.eururo.2017.03.031

Published Print: 2017-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Dutta, Aditya

Panja, Sukanya

Virk, Renu K.

Kim, Jaime Yeji

Zott, Roseann

Cremers, Serge

Golombos, David M.

Liu, Deli

Mosquera, Juan Miguel

Mostaghel, Elahe A.

Barbieri, Christopher E.

Mitrofanova, Antonina

Abate-Shen, Cory
License Information

Text and Data Mining valid from 2017-10-01
More Information

This article is maintained by: Elsevier

Article Title: Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition

Journal Title: European Urology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eururo.2017.03.031

Content Type: article

Copyright: © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Document is current

Any future updates will be listed below